Global E-Cigarette Market Analysis and Forecast Report

Aug.19.2022
Global E-Cigarette Market Analysis and Forecast Report
This report provides comprehensive data regarding emerging trends, market drivers, growth opportunities, and limitations in the global e-cigarette market.

This report presents comprehensive data on emerging trends, market drivers, growth opportunities, and limiting factors that could change the dynamics of the e-cigarette market. The report assesses the global market size of e-cigarettes and examines strategic models employed by international companies. Additionally, the report evaluates the market size based on revenue forecasts for the projected period. All data, such as percentage share splits and segmentations, were obtained from secondary sources and validated through primary sources.


The report focuses on key players and manufacturers, as well as their latest strategies including new product launches, partnerships, joint ventures, technology, regional and industry competition segments, profit ratios, and investment philosophies. It offers a precise evaluation of effective manufacturing technologies, advertising technologies, market share size, growth rate, scale, revenue, sales, and value chain analysis.


The report analyzed the top brands in the e-cigarette market, which include MCIG Inc., Nicotek LLC, J WELL France, Altria Group, International Vapor Group, Njoy Inc, British American Tobacco, Vmr Flavors LLC, Philip Morris International Inc, Healthier Choices Management Corp (Ruthless Vapor Corp), Reynolds American Inc, Japan Tobacco, and Imperial Brands.


Statement


This article is compiled from third-party information and is intended for industry professionals to exchange and learn from.


This article does not reflect the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the article's content. The compilation of this article is intended solely for industry exchange and research purposes.


Due to limitations in the translation proficiency, the compiled article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, and foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. If there is infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia Sues Juul Over Youth Nicotine Addiction
British Columbia has filed a civil lawsuit against Juul Labs, alleging the company fuelled youth nicotine addiction through highly addictive products and deceptive marketing practices. The claim was submitted to the B.C. Supreme Court under the newly enacted Vaping Product Damages and Health Care Costs Recovery Act.
Dec.15 by 2FIRSTS.ai
China Boton Group Resumes Trading, Soars 55.56% to 52-Week High; Signs Land Acquisition Agreement with Shenzhen Government - Reuters/AP
China Boton Group Resumes Trading, Soars 55.56% to 52-Week High; Signs Land Acquisition Agreement with Shenzhen Government - Reuters/AP
China Boton Group (HK.3318) resumed trading on December 10, opening at 2.800 HKD and surging 55.56%.
Dec.10 by 2FIRSTS.ai
Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices
Product | Up to 100,000 Puffs and Over 2,000 Puffs per ml: MASKKING, MR FOG, HYPERBAR Roll Out Ultra High-Puff New Devices
In 2025, disposable vapes are shifting from a “puff count race” to a focus on user experience. While 30,000–50,000 puffs has become mainstream, brands like MASKKING, MR FOG, and HYPERBAR are still launching higher-capacity products in the 60,000–100,000 puff range. Models with disclosed tank sizes all exceed 2,000 puffs per mL and commonly feature adjustable wattage and enhanced interactive functions.
Nov.14 by 2FIRSTS.ai
Philippine DOH Calls for Nationwide Vape Ban Amid Surging Youth Use
Philippine DOH Calls for Nationwide Vape Ban Amid Surging Youth Use
The Philippine Department of Health (DOH) has warned that youth vaping has reached alarming levels. Health Secretary Ted Herbosa stressed that despite regulations limiting vaping to adults aged 18 and above, minors—many in school uniforms—are frequently seen using vape devices. Criticizing the industry’s youth-targeted marketing tactics, Herbosa said the government should consider a nationwide total ban on vape products.
Nov.24 by 2FIRSTS.ai
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus is discussing the introduction of criminal liability for selling vapes and related nicotine-containing products to minors. During a meeting of the expert council, a draft law regulating tobacco and non-tobacco nicotine products received support from most members.
Dec.15 by 2FIRSTS.ai
 Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
Breaking News | FDA Adds on! Plus Nicotine Pouches to PMTA-Authorized List
The U.S. Food and Drug Administration (FDA) has added ON! Plus nicotine pouch products to its list of authorized products, disclosing that the brand has received Marketing Granted Orders (MGO) through the Premarket Tobacco Product Application (PMTA) pathway. The update makes on! Plus the second nicotine pouch brand authorized via PMTA, following ZYN. As of publication, the FDA had not issued a separate press release on the decision.
News
Dec.20